Evidence map›Paper›PMID 24247266›Full record

ArticleJournal of innate immunity2014

Methionine sulfoxide reductases protect against oxidative stress in Staphylococcus aureus encountering exogenous oxidants and human neutrophils.

Yun Yun Pang, Jamie Schwartz, Sarah Bloomberg, Jeffrey M Boyd, Alexander R Horswill, William M Nauseef

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Treatment ofAntimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. ThebioRxiv : the preprint server for biology · 2024
    Article
  9. Loratadine Combats Methicillin-ResistantACS infectious diseases · 2024
    Article
  10. Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Virulence · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yun Yun PangInflammation Program, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Jamie Schwartz
Sarah Bloomberg
Jeffrey M Boyd
Alexander R Horswill
William M Nauseef
University of Iowa · USRutgers, The State University of New Jersey · USUnited States Department of Veterans Affairs · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI PATRICK T O'SHAUGHNESSY · 1990 to 2026
$40.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Quorum sensing-dependent interactions with biofilms and innate immunity defensesR01AI078921 · NIAID · UNIVERSITY OF IOWA · PI HORSWILL, ALEXANDER R · 2008 to 2012
$2.0M
Consequences of interactions between human neutrophils and Staphylococcus aureusR01AI116546 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2015 to 2019
$1.8M
Innate immune defense against community associated methicillin-resistant S.aureusR01AI070958 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2008 to 2011
$1.3M
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responsesI01BX000513 · VA · IOWA CITY VA MEDICAL CENTER · PI NAUSEEF, WILLIAM M. · 2009 to 2017
–
BLRD VA I01 BX000513NIAID NIH HHS R01 AI070958NIAID NIH HHS R01 AI078921NIAID NIH HHS R01AI078921NIAID NIH HHS R01 AI07958NIAID NIH HHS R01 AI116546NIEHS NIH HHS P30 ES005605NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

To establish infection successfully, Staphylococcus aureus must evade clearance by polymorphonuclear neutrophils (PMN). We studied the expression and regulation of the methionine sulfoxide reductases (Msr) that are involved in the repair of oxidized staphylococcal proteins and investigated their influence on the fate of S. aureus exposed to oxidants or PMN. We evaluated a mutant deficient in msrA1 and msrB for susceptibility to hydrogen peroxide, hypochlorous acid and PMN. The expression of msrA1 in wild-type bacteria ingested by human PMN was assessed by real-time PCR. The regulation of msr was studied by screening a library of two-component regulatory system (TCS) mutants for altered msr responses. Relative to the wild-type bacteria, bacteria deficient in Msr were more susceptible to oxidants and PMN. Upregulation of staphylococcal msrA1 occurred within the phagosomes of normal PMN and PMN deficient in NADPH oxidase activity. Furthermore, PMN granule-rich extract stimulated the upregulation of msrA1. Modulation of msrA1 within PMN was shown to be partly dependent on the VraSR TCS. Msr contributes to staphylococcal responses to oxidative attack and PMN. Our study highlights a novel interaction between the oxidative protein repair pathway and the VraSR TCS that is involved in cell wall homeostasis.

Indexed as

Bacterial ProteinsCells, CulturedCell WallDNA-Binding ProteinsGene Expression RegulationHumansHydrogen PeroxideHypochlorous AcidImmune EvasionMethionine Sulfoxide ReductasesMutationNeutrophilsOxidantsOxidative StressStaphylococcal InfectionsStaphylococcus aureusBacterial ProteinsDNA-Binding ProteinsHydrogen PeroxideHypochlorous AcidMethionine Sulfoxide ReductasesOxidantsVraR protein, Staphylococcus aureusVraS protein, Staphylococcus aureus

Identifiers

PMID24247266
PMCPMC3972283
OpenAlexW2018369686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.